Barbara Davis Center for Childhood Diabetes
The Barbara Davis Center for Childhood Diabetes is a University of Colorado Anschutz academic center providing specialized type 1 diabetes clinical care, screening, and translational research across pediatric, adult, and eye clinics, supported by dedicated core laboratory facilities.
- Company typePrivate
- Founded-
- HeadquartersAurora, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Barbara Davis Center for Childhood Diabetes does
The Barbara Davis Center for Childhood Diabetes is a specialized type 1 diabetes care and research center operating as a department within the University of Colorado Anschutz Medical Campus School of Medicine, governed by The Regents of the University of Colorado. It provides clinical care across four specialty clinics—Pediatric, Adult, Eye, and Early T1D—serving children, adolescents, and adults with type 1 diabetes through on-site appointments, outreach telemedicine clinics, and e-Consult services for external providers. The center also operates the STOP-T1D autoantibody screening program to identify at-risk individuals and an Early T1D Clinic for recently diagnosed patients.
The center's research operations are organized into four divisions (Basic and Translational Research, Diabetes Research Center, Clinical Research, and Clinical Epidemiology) and supported by four core laboratory facilities: Autoantibody/HLA testing, Tissue Procurement and Processing, Cell and Tissue Analysis, and Molecular Biology. These facilities provide specialized infrastructure for diabetes research and clinical trial activity. The center is led by Executive Director Marian Rewers, MD, PhD, and is closely affiliated with Children's Hospital Colorado (sharing campus and IT infrastructure including the MyChart patient portal) and the Children's Diabetes Foundation, which provides significant philanthropic support.
Revenue is generated through professional clinical services billed to insurers and patients, supplemented by research grants and philanthropic donations. The center operates as a state-supported public institution, not a venture-backed or publicly traded entity, with no disclosed pricing, revenue figures, or funding rounds. Its value proposition rests on combining clinical excellence with cutting-edge research, access to clinical trials, and specialized expertise in type 1 diabetes across the lifespan.
Barbara Davis Center for Childhood Diabetes firmographics
Firmographics- Name
- Barbara Davis Center for Childhood Diabetes
- Legal name
- The Regents of the University of Colorado
- Website
- https://barbaradaviscenter.org
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- The Barbara Davis Center for Childhood Diabetes is a University of Colorado Anschutz academic center providing specialized type 1 diabetes clinical care, screening, and translational research across pediatric, adult, and eye clinics, supported by dedicated core laboratory facilities.
- Ownership category
- akta.pro rank
Barbara Davis Center for Childhood Diabetes industry classification
Industry- Product category
- Specialty Diabetes Care and Research
- NAICS
- Offices of Physicians (62111), Offices of Physicians (6211)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Type 1 Diabetes Care (HLAKADAB)
- akta.pro secondary industry
- Diabetes (General) (HLAKADAA)
Keywords
Where Barbara Davis Center for Childhood Diabetes is headquartered
LocationHeadquarters
- HQ city
- Aurora
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Barbara Davis Center for Childhood Diabetes business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Others
Revenue model
- Healthcare Services Revenue: Revenue generated from providing clinical care services to patients with type 1 diabetes across pediatric, adult, and specialty eye clinics. Services are billed through standard healthcare insurance and payment mechanisms.
- Research Funding and Grants: The center receives research funding through grants and philanthropy to support its diabetes research mission, including basic and translational research, clinical research, and diabetes prevention initiatives.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels2 records
Barbara Davis Center for Childhood Diabetes product offering
Product offeringCore offering
The Barbara Davis Center for Diabetes provides specialized clinical care and research services for type 1 diabetes across the lifespan. It operates Pediatric, Adult, Eye, and Early T1D clinics, offers autoantibody screening through the STOP-T1D program, and supports research through four divisions (Basic and Translational Research, Diabetes Research Center, Clinical Research, and Clinical Epidemiology) backed by four core laboratories. It is part of the University of Colorado Anschutz Medical Campus and closely affiliated with the Children's Diabetes Foundation.
Product overview
The Barbara Davis Center is a specialized diabetes care and research center at the University of Colorado Anschutz Medical Campus, providing a comprehensive suite of clinical services for type 1 diabetes patients across the lifespan. The center operates multiple specialty clinics including Pediatric, Adult, Eye, and Early T1D clinics, supported by advanced autoantibody testing and screening programs. Research operations are organized into Basic and Translational Research, Diabetes Research Center, Clinical Research, and Clinical Epidemiology divisions, each contributing to understanding, prevention, and treatment of diabetes. Core laboratory facilities support this research mission with specialized services in autoantibody/HLA testing, tissue processing, cell and tissue analysis, and molecular biology. The center also provides e-consultation services for external providers and operates outreach clinics via telemedicine to extend specialized diabetes care beyond the main campus.
Differentiator
Problem solved
Functional benefit
Products and services
- Pediatric Clinic Specialized type 1 diabetes care clinic for children and adolescents, providing diagnosis, treatment, education, and ongoing disease management for pediatric patients.
- Adult Clinic Specialized type 1 diabetes care clinic for adult patients, offering continuous care, treatment, and management services across the lifespan.
- Eye Clinic Ophthalmology clinic specializing in diabetes-related eye complications, providing screening and treatment for diabetic retinopathy and other diabetes-associated eye conditions.
- Early T1D Clinic Specialized clinic for patients recently diagnosed with type 1 diabetes, providing early intervention, education, and disease management services.
- Autoantibody Testing (STOP-T1D) Screening service for autoantibodies to identify individuals at risk for developing type 1 diabetes, delivered as part of the STOP-T1D program.
- Basic and Translational Research Division Research division focused on fundamental scientific investigation of diabetes mechanisms, disease progression, and potential therapeutic interventions.
- Diabetes Research Center Comprehensive diabetes research center dedicated to understanding diabetes pathophysiology and developing novel treatment approaches.
- Clinical Research Division Division conducting clinical trials and human studies to evaluate new diabetes treatments, devices, and management strategies.
- Clinical Epidemiology Division Research division studying the distribution and determinants of diabetes in populations to inform prevention and treatment strategies.
- Autoantibody/HLA Core Facility Core laboratory facility providing autoantibody and HLA (human leukocyte antigen) testing services for diabetes research and clinical purposes.
- Tissue Procurement and Processing Core Facility Core facility for obtaining, processing, and preserving biological tissue samples for diabetes research.
- Cell and Tissue Analysis Core Facility Core facility providing advanced cellular and tissue analysis services including islet isolation and characterization for diabetes research.
- Molecular Biology Core Facility Core facility offering molecular biology services including gene expression analysis, sequencing, and other molecular techniques for diabetes research.
- e-Consults Electronic consultation service allowing external and referring providers to submit asynchronous interprofessional consultations for established patients or second opinions.
- Outreach Telemedicine Clinics Remote clinical services bringing type 1 diabetes care to patients in Grand Junction and other underserved areas through telemedicine clinics.
Companies that use Barbara Davis Center for Childhood Diabetes
Customer profileSegments2 records
Ideal customer profiles3 records
Barbara Davis Center for Childhood Diabetes technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Barbara Davis Center for Childhood Diabetes partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Children's Hospital ColoradocoreAffiliated with Children's Hospital Colorado, sharing the same healthcare campus and collaborating on pediatric patient care. The center's MyChart patient portal is hosted on Children's Colorado's systems, indicating integrated healthcare information technology infrastructure.
- University of Colorado Anschutz Medical CampuscoreThe Barbara Davis Center is an academic department within the University of Colorado Anschutz Medical Campus, benefiting from institutional resources, accreditation, and integration with other medical school departments including Schools of Dental Medicine, Nursing, Pharmacy, and Public Health.
Scale indicators1 record
Recent moves5 records
Expansion highlights4 records
Barbara Davis Center for Childhood Diabetes competitors and assessment
Company assessmentDirect peers
- Joslin Diabetes Center: Harvard-affiliated specialty diabetes center offering integrated clinical care, research, and education across all forms of diabetes. Directly comparable to BDC in mission, clinical model, and research orientation, with a longer national brand history.
- Stanford Diabetes Research Center: Stanford School of Medicine center combining clinical research and basic science in T1D and T2D. Comparable to BDC in research-driven model with cross-disciplinary programs and NIH-funded center status.
- Vanderbilt Diabetes Research and Training Center: NIDDK-funded Diabetes Research Center at Vanderbilt providing translational research, clinical care, and training. Comparable to BDC as an NIH-designated specialty center with overlapping clinical and research missions.
- Naomi Berrie Diabetes Center: Columbia University-affiliated diabetes center combining pediatric and adult T1D care with translational research. Comparable operating model and patient mix to BDC, with a strong research footprint in immunology and beta-cell biology.
- University of Michigan Caswell Diabetes Institute: University of Michigan-wide institute integrating T1D and T2D clinical care, research, and training. Comparable to BDC in academic structure, multi-disciplinary clinical services, and a strong bench-to-bedside orientation.
- Diabetes Research Institute (DRI) at the University of Miami: University of Miami Miller School of Medicine center focused on curing T1D through islet transplantation and beta-cell regeneration. Comparable to BDC in combining clinical care with a dedicated diabetes research mission and high-profile translational programs.
Broad incumbents
- Medtronic Diabetes: Major manufacturer of insulin pumps and automated insulin delivery systems. Adjacent to BDC's clinical and research operations; a likely trial sponsor and device partner rather than a direct competitor.
- Dexcom: Continuous glucose monitoring market leader. Not a direct service competitor to BDC, but a device partner whose CGM data is integral to BDC's clinical care and research workflows.
Others
- JDRF (formerly Juvenile Diabetes Research Foundation): Largest non-profit funder of T1D research globally. Not a direct competitor but a critical funding partner and ecosystem player for any academic T1D center, including BDC.
- TrialNet: International network conducting T1D screening and prevention trials. Related ecosystem participant that collaborates with centers like BDC on autoantibody screening and prevention studies such as STOP-T1D.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Barbara Davis Center for Childhood Diabetes social profiles
Digital presenceBarbara Davis Center for Childhood Diabetes financial estimates
Financial estimateRevenue estimate
Valuation estimate
Barbara Davis Center for Childhood Diabetes leadership team
Management profileNumber of profiles
Profiles1 record
Barbara Davis Center for Childhood Diabetes funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Barbara Davis Center for Childhood Diabetes M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Barbara Davis Center for Childhood Diabetes
What does Barbara Davis Center for Childhood Diabetes do?
The Barbara Davis Center for Diabetes provides specialized clinical care and research services for type 1 diabetes across the lifespan. It operates Pediatric, Adult, Eye, and Early T1D clinics, offers autoantibody screening through the STOP-T1D program, and supports research through four divisions (Basic and Translational Research, Diabetes Research Center, Clinical Research, and Clinical Epidemiology) backed by four core laboratories. It is part of the University of Colorado Anschutz Medical Campus and closely affiliated with the Children's Diabetes Foundation.
Is Barbara Davis Center for Childhood Diabetes a public or private company?
Barbara Davis Center for Childhood Diabetes is a private company. It is classified as state government owned and is currently operating.
When was Barbara Davis Center for Childhood Diabetes founded?
Barbara Davis Center for Childhood Diabetes was founded in -1. It employs 11 to 50 people.
Where is Barbara Davis Center for Childhood Diabetes based?
Barbara Davis Center for Childhood Diabetes is headquartered in Aurora, United States, in the North America region.
How does Barbara Davis Center for Childhood Diabetes make money?
Two revenue lines are on record. Healthcare Services Revenue is the primary driver. The others are research Funding and Grants.
Who are Barbara Davis Center for Childhood Diabetes's main competitors?
Direct peers on record are Joslin Diabetes Center, Stanford Diabetes Research Center, Vanderbilt Diabetes Research and Training Center, Naomi Berrie Diabetes Center, University of Michigan Caswell Diabetes Institute and Diabetes Research Institute (DRI) at the University of Miami. Broad incumbents are Medtronic Diabetes and Dexcom. Others are JDRF (formerly Juvenile Diabetes Research Foundation) and TrialNet.
Does Barbara Davis Center for Childhood Diabetes have an API?
No public API is recorded for Barbara Davis Center for Childhood Diabetes.
What industry is Barbara Davis Center for Childhood Diabetes in?
Barbara Davis Center for Childhood Diabetes's product category is Specialty Diabetes Care and Research. Its primary akta.pro industry code is HLAKADAB, Type 1 Diabetes Care, with a secondary code of HLAKADAA, Diabetes (General). Its NAICS code is 62111 and its SIC code is 8011.